WHO ICTRP trial
Effect of royal jelly in treatment of stroke
IRCT20180818040827N4 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20180818040827N4 |
|---|---|
| Public title | Effect of royal jelly in treatment of stroke |
| Scientific title | The effects of royal jelly supplementation on inflammatory status, oxidative stress, mental health, cognitive function, disease severity and quality of life in patients with ischemic stroke |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Ischemic stroke. Cerebellar stroke syndrome;G46.4 |
| Interventions | Intervention 1: Intervention group: The intervention group will receive one tablet of Royal Jelly (containing 1000 mg of Royal Jelly powder) daily after breakfast for 12 weeks. Royal Jelly supplement will be provided by Koozeh Asal Aria… |
| Registration date | Oct 16, 2021 |
| Target size | 64 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: